CN Patent

CN108348484B — 阳离子甾体抗微生物盐

Assigned to Brigham Young University · Expires 2021-12-17 · 4y expired

What this patent protects

本文中公开了阳离子甾体抗微生物剂(“CSA”或“塞拉集宁”)的酸加成盐及其制备方法。鉴定了特别有利的盐形式，例如1，5‑萘二磺酸加成盐和硫酸盐加成盐。所述酸加成盐可配制成用于治疗患有响应于CSA之疾病的对象，包括但不限于治疗细菌感染。一些实施方案包括制剂和施用CSA之酸加成盐的方法。

USPTO Abstract

本文中公开了阳离子甾体抗微生物剂(“CSA”或“塞拉集宁”)的酸加成盐及其制备方法。鉴定了特别有利的盐形式，例如1，5‑萘二磺酸加成盐和硫酸盐加成盐。所述酸加成盐可配制成用于治疗患有响应于CSA之疾病的对象，包括但不限于治疗细菌感染。一些实施方案包括制剂和施用CSA之酸加成盐的方法。

Drugs covered by this patent

besifloxacin-hydrochloride (BESIFLOXACIN HYDROCHLORIDE)

Patent Metadata

Patent number: CN108348484B
Jurisdiction: CN
Classification: —
Expires: 2021-12-17
Drug substance claim: No
Drug product claim: No
Assignee: Brigham Young University
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.